4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001104659-15-013142
CIK 0001600132operating
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 9:39 PM ET
Size
4.5 KB
Accession
0001104659-15-013142
Insider Transaction Report
Form 4
MEGLASSON MARTIN
Chief Scientific Officer
Transactions
- Purchase
Common Stock
2015-02-19$12.00/sh+12,000$144,000→ 18,386 total
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 9:39 PM ET
- Size
- 4.5 KB